Outlook Therapeutics, Inc. (OTLK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 09-30. Amounts in USD.

Revenue Annual

0 3M 6M 9M FY16: 3M FY17: 3.8M FY18: 3.1M FY19: 8.1M FY25: 1.4M FY16 FY17 FY18 FY19 FY25

Gross Profit Annual

0 20K 40K 60K FY25: 57.2K FY25

Operating Income Annual

-75M -50M -25M 0 25M 50M 75M FY21: -51.7M FY22: -63.1M FY23: -53.1M FY24: -71.7M FY25: -67.1M FY21 FY22 FY23 FY24 FY25

Net Income Annual

-90M -60M -30M 0 30M 60M 90M FY21: -53.2M FY22: -66.1M FY23: -59M FY24: -75.4M FY25: -62.4M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 500K 1M 1.5M FY25: 1.4M FY25

Operating Cash Flow Annual

-75M -50M -25M 0 25M 50M 75M FY21: -54.3M FY22: -56.7M FY23: -43M FY24: -68.8M FY25: -51.8M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY15: -36.3M FY16: -46.6M FY17: -15.8M FY18: -35.8M FY19: -32.7M FY15 FY16 FY17 FY18 FY19

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 80M 160M 240M FY21: 152.7M FY22: 212.1M FY23: 12.5M FY24: 18.5M FY25: 34.8M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-12.00 -8.00 -4.00 0.00 4.00 8.00 12.00 Q4 '20: -0.99 Q1 '21: -0.49 Q2 '21: -0.22 Q3 '21: -0.26 Q4 '21: -0.36 Q1 '22: -0.32 Q2 '22: -0.32 Q3 '22: -0.33 Q4 '22: -0.31 Q1 '23: -0.31 Q2 '23: -0.74 Q3 '23: -2.27 Q4 '23: -3.20 Q1 '24: -3.98 Q2 '24: -11.47 Q3 '24: -10.75 Q4 '25: -1.52 Q1 '26: -2.62 Q2 '26: -1.17 Q3 '26: -0.77 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.